COQ5
2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
Also known as: COQ5_HUMAN, MGC4767
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5HYK3
- Gene
- COQ5
- Ensembl
- ENSG00000110871
- Chromosome
- 12
- Canonical length
- 327 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Mitochondria
OverviewNCBI Gene
Enables 2-methoxy-6-polyprenyl-1,4-benzoquinol methyltransferase activity. Involved in methylation and ubiquinone biosynthetic process. Located in mitochondrial inner membrane and mitochondrial matrix. Part of ubiquinone biosynthesis complex. Implicated in primary coenzyme Q10 deficiency 9. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q5HYK3|COQ5
1 MAAPGSCALW SYCGRGWSRA MRGCQLLGLR SSWPGDLLSA RLLSQEKRAA ETHFGFETVS
61 EEEKGGKVYQ VFESVAKKYD VMNDMMSLGI HRVWKDLLLW KMHPLPGTQL LDVAGGTGDI
121 AFRFLNYVQS QHQRKQKRQL RAQQNLSWEE IAKEYQNEED SLGGSRVVVC DINKEMLKVG
181 KQKALAQGYR AGLAWVLGDA EELPFDDDKF DIYTIAFGIR NVTHIDQALQ EAHRVLKPGG
241 RFLCLEFSQV NNPLISRLYD LYSFQVIPVL GEVIAGDWKS YQYLVESIRR FPSQEEFKDM
301 IEDAGFHKVT YESLTSGIVA IHSGFKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COQ5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 92 nTPM
- tongue: 65 nTPM
- liver: 57 nTPM
- heart muscle: 39 nTPM
- kidney: 36 nTPM
- choroid plexus: 35 nTPM
Single-cell type
- cytotrophoblasts: 90 nCPM
- migrating cytotrophoblasts: 77 nCPM
- late primary spermatocytes: 73 nCPM
- syncytiotrophoblasts: 69 nCPM
- hofbauer cells: 57 nCPM
- early spermatids: 56 nCPM
Immune cell
- myeloid DC: 61 nTPM
- NK-cell: 61 nTPM
- T-reg: 57 nTPM
- naive CD4 T-cell: 57 nTPM
- total PBMC: 55 nTPM
- naive B-cell: 53 nTPM
Brain region
- white matter: 34 nTPM
- choroid plexus: 30 nTPM
- basal ganglia: 26 nTPM
- medulla oblongata: 26 nTPM
- cerebellum: 26 nTPM
- pons: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COQ5.
Disease | AllUniProt
Conditions COQ5 is implicated in, by any mechanism.
- Coenzyme Q10 deficiency, primary, 9 (COQ10D9) MIM:619028
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 72 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Coenzyme q10 deficiency, primary, 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.36
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 2-methoxy-6-polyprenyl-1
- 4-benzoquinol methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- UbiE/COQ5 methyltransferase, conserved site
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- UbiE/COQ5 methyltransferase
- ubiE/COQ5 methyltransferase family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COQ5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COQ5 as an antibody target. Whether an autoantibody or antibody against COQ5 could matter depends on whether native COQ5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COQ5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label COQ5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...